Self-supplying Cu2+ and oxidative stress synergistically enhanced disulfiram-mediated melanoma chemotherapy

Author:

Gao Yingqian1,Cai Xiaojun2,Zou Weijuan2,Tang Xiuzhen2,Jiang Lixian2,Hao Junnian2,Zheng Yuanyi2,Ye Xinhua1,Ying Tao2,Li Ao1

Affiliation:

1. Department of Ultrasound in Medicine, The First Affiliated Hospital of Nanjing Medical University

2. Department of Ultrasound in Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Abstract

Abstract Background Disulfiram (DSF) combined Cu2+ ions can target and kill cancer cells by disrupting cellular degradation of extruded proteins, and has therefore received particular attention for its tumor chemotherapeutic potential. However, the Cu2+/DSF ratio and oxidative environment can affect the efficacy of DSF-mediated chemotherapy. Herein, self-supplying Cu2+ and oxidative stress synergistically enhanced DSF-mediated chemotherapy is proposed for melanoma based on PVP-coated CuO2 nanodots (CPNDs). Results Once ingested, DSF is broken down to diethyldithiocarbamate (DTC), which is delivered into the tumor via circulation. Under the acidic tumor microenvironment, CPNDs produce sufficient Cu2+ and H2O2. DTC readily chelates Cu2+ ions to generate CuET, which shows antitumor efficacy. CuET-mediated chemotherapy can be enhanced by H2O2. Sufficient Cu2+ generation can guarantee maximum efficacy of DSF-mediated chemotherapy. Furthermore, Cu2+ can react with H2O2 to generate toxic hydroxyl radicals (•OH) via a Fenton-like reaction, promoting the efficacy of CuET. As a result, accompanied with oral uptaking of DSF and intratumoral injection of CPNDs strategy, the treatment achieves remarkable antitumor activity, which has been systematically verified both in vivo and in vitro assays. Conclusion This study hypothesizes that employing CPNDs instead of Cu2+ ions could generate H2O2 for Cu2+ and oxidative stress synergistically enhanced DSF-mediated melanoma chemotherapy, providing a simple but efficient strategy for achieving chemotherapeutic effeicacy.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3